Boston Partners Sells 35,203 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

Boston Partners decreased its holdings in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 44.6% during the 4th quarter, Holdings Channel reports. The firm owned 43,750 shares of the company’s stock after selling 35,203 shares during the quarter. Boston Partners’ holdings in Viemed Healthcare were worth $351,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Wasatch Advisors LP boosted its holdings in shares of Viemed Healthcare by 19.6% during the 3rd quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company’s stock worth $13,552,000 after buying an additional 303,277 shares in the last quarter. Rice Hall James & Associates LLC bought a new position in Viemed Healthcare during the fourth quarter worth $2,083,000. First Eagle Investment Management LLC grew its holdings in Viemed Healthcare by 196.5% in the fourth quarter. First Eagle Investment Management LLC now owns 328,824 shares of the company’s stock worth $2,637,000 after purchasing an additional 217,923 shares during the period. Victory Capital Management Inc. increased its stake in Viemed Healthcare by 748.2% in the third quarter. Victory Capital Management Inc. now owns 108,497 shares of the company’s stock valued at $795,000 after purchasing an additional 95,706 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in shares of Viemed Healthcare by 151.7% during the third quarter. JPMorgan Chase & Co. now owns 98,798 shares of the company’s stock valued at $724,000 after purchasing an additional 59,538 shares during the period. Institutional investors and hedge funds own 74.24% of the company’s stock.

Viemed Healthcare Stock Performance

Shares of VMD opened at $7.24 on Monday. Viemed Healthcare, Inc. has a one year low of $6.21 and a one year high of $9.81. The company has a market cap of $286.14 million, a PE ratio of 26.81 and a beta of 1.50. The stock has a 50-day moving average of $7.91 and a 200-day moving average of $8.20. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.